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Background
IL-28B single nucleotide polymorphisms (SNPs) strongly
influence both spontaneous HCV clearance and
response to peginterferon-ribavirin therapy. There is no
information about the impact of IL28B SNPs on the nat-
ural history of HCV liver disease and/or the rate of ele-
vated liver enzymes.
Methods
A cohort of HIV/HCV coinfected individuals with nor-
mal (<41 IU/L) or elevated (41 IU/L) ALT levels for >12
months were screened for the rs12979860 SNP at the
IL-28B gene. The proportion of patients with the favor-
able (CC) or unfavorable (CT/TT) genotypes were com-
pared in both groups.
Results
A total of 124 patients (44% normal ALT levels, median
age 42 years, 68% males, 93% IDUs, 33% alcohol abuse,
5% HBsAg+, median CD4 count 511 cells/µL, median
serum HCV-RNA 6.05 log10 copies/mL, 62% HCV geno-
type 1) were analyzed. Overall 34% of the whole popula-
tion displayed the IL-28B CC genotype. When comparing
ALT groups, 18 (32.7%) with normal ALT showed CC vs
25 (36.2%) with elevated ALT (p=0.71). Using elastome-
try (FibroScan), liver fibrosis estimates were significantly
lower at baseline in patientsw i t hn o r m a lv se l e v a t e d
ALT (6.3±2 vs 14.4±12 kPa, respectively, p<0.001). Other
differences amongst groups were not significant, as fol-
lows: baseline serum HCV-RNA (5.95 vs 6.05 log10 IU/
mL, p=0.62), CD4 counts (499 vs 543 cells/µl, p=0.34),
and prothrombin activity (91% in both groups, p=0.99).
Patients with normal vs elevated ALT were found to be
coinfected more frequently with HCV genotypes 1 or 4
(45% vs 26%, p=0.02).
Conclusions
IL28B genotypes do not influence ALT levels in HIV-
HCV coinfected patients. Higher ALT levels are asso-
ciated with a greater extent of liver fibrosis.
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